Thomas J. Quinn
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Advanced Radiotherapy Techniques, Virus-based gene therapy research, Cellular transport and secretion, Neurological disorders and treatments
Most-Cited Works
- → Rab11a and HSP90 Regulate Recycling of Extracellular α-Synuclein(2009)132 cited
- → Intramyocardial transplantation of cardiac telocytes decreases myocardial infarction and improves post‐infarcted cardiac function in rats(2014)102 cited
- → Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients(2016)71 cited
- → Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape(2016)67 cited
- → Extracellular signal-regulated kinase is involved in alpha-synuclein-induced mitochondrial dynamic disorders by regulating dynamin-like protein 1(2012)62 cited
- → Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy(2017)59 cited
- → Salivary DJ-1 could be an indicator of Parkinson's disease progression(2014)52 cited
- → Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model(2012)44 cited
- → Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity(2012)40 cited
- → Loss ofMEN1activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis(2016)35 cited